SATB2 and neoplasm: (3) SATB2 shows an especially high prognostic relevance in uni- and multivariate analyses of high-risk clinicopathological subgroups (high tumour budding/UICC stage III) and identifies CRCs with a particularly aggressive disease course in these high-risk scenarios.